pimagedine has been researched along with ramipril in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Clavant, SP; Comper, WD; Jerums, G; Kemp, BE; Kiriazis, Z; Osicka, TM; Panagiotopoulos, S; Pike, RN; Pratt, LM; Russo, LM; Yu, Y | 1 |
| Jerums, G; Kemp, BE; Lee, V; Osicka, TM; Panagiotopoulos, S; Yu, Y | 1 |
| Comper, WD; Jerums, G; Kiriazis, Z; Osicka, TM; Pratt, LM | 1 |
| Brammar, GC; Burns, WC; Burrell, LA; Burrell, LM; Cooper, ME; Forbes, JM; Grant, SL; Jerums, G; Lee, F; Osicka, TM; Thallas, V; Thomas, MC | 1 |
| Cooper, M; Forbes, J; Jerums, G; Osicka, T; Panagiotopoulos, S | 1 |
1 review(s) available for pimagedine and ramipril
| Article | Year |
|---|---|
Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Inhibitors; Forecasting; Glycation End Products, Advanced; Guanidines; Humans; Protein Kinase C; Ramipril; Renin-Angiotensin System; Thiazoles | 2003 |
5 other study(ies) available for pimagedine and ramipril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.
Topics: Albuminuria; Animals; Antihypertensive Agents; Cathepsins; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Guanidines; Hemodynamics; Kidney; Kidney Glomerulus; Lysosomes; Male; Protein Kinase C; Ramipril; Rats; Rats, Sprague-Dawley; Reference Values | 2000 |
Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glycated Hemoglobin; Glycation End Products, Advanced; Guanidines; Hypoglycemic Agents; Insulin; Kidney Glomerulus; Male; Mesenteric Arteries; Protein Kinase C; Ramipril; Rats; Rats, Sprague-Dawley; Retina | 2001 |
Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Chromatography, Ion Exchange; Dextran Sulfate; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Filtration Rate; Guanidines; Kidney; Kinetics; Lysosomes; Male; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Sulfatases; Sulfates; Tritium | 2001 |
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Guanidines; Male; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Time Factors | 2002 |